Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
British Journal of Hospital Medicine|June 1, 1990
Non-surgical therapy for malignant brain tumoursR P Moseley, H B CoakhamNeurosurgery|August 1, 1989
Cerebral distribution of immunoconjugate after treatment for neoplastic meningitis using an intrathecal radiolabeled monoclonal antibodyJ C Benjamin, T Moss, R P Moseley, et al.Cancer Research|May 15, 1989
Pharmacokinetics and tumor localization of 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignanciesM R Zalutsky, R P Moseley, H B Coakham, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1989
Neoplastic meningitis in malignant melanoma: diagnosis with monoclonal antibodiesR P Moseley, A G Davies, S P Bourne, et al.International Journal of Cancer|August 19, 1992
Immunoreactivity, pharmacokinetics and bone marrow dosimetry of intrathecal radioimmunoconjugatesR P Moseley, V Papanastassiou, M R Zalutsky, et al.Cancer Research|July 1, 1990
Monoclonal antibody and F(ab')2 fragment delivery to tumor in patients with glioma: comparison of intracarotid and intravenous administrationM R Zalutsky, R P Moseley, J C Benjamin, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1991
Carcinomatous meningitis: antibody-guided therapy with I-131 HMFG1R P Moseley, J C Benjamin, R D Ashpole, et al.The Journal of Pathology|April 1, 1997
An immunocytochemical study of MHC class I expression on human Langerhans cells and melanocytesR P Moseley, J I Brown, J Auld, et al.British Journal of Cancer|October 1, 1990
Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitisR P Moseley, A G Davies, R B Richardson, et al.International Journal of Cancer|September 15, 1989
HMFG1 antigen: a new marker for carcinomatous meningitisR P Moseley, K Oge, S Shafqat, et al.Pageof 2